Navigation Links
Eisai Oncology to Present New Research on Product Portfolio and Pipeline at ASCO Annual Meeting
Date:5/17/2012

WOODCLIFF LAKE, N.J., May 17, 2012 /PRNewswire/ -- Eisai announced today that 15 abstracts highlighting new study results will be presented during the 48th Annual Meeting of the American Society of Clinical Oncology (ASCO), taking place in Chicago from June 1 to June 5, 2012.

These studies highlight Eisai's current product portfolio and oncology pipeline, reinforcing the company's commitment to patients and their families affected by cancer.

"Our human health care mission is to help address unmet medical needs and increase benefits to patients and their families," said Takashi Owa, Ph.D., Chief Scientific Officer, Eisai Product Creation Systems. "Our portfolio of oncology compounds and therapies underscores our commitment to this important mission."

The following Eisai abstracts are accepted for presentation at this year's ASCO meeting:ProductAbstract NameEribulin Mesylate

Abstract No:

TPS 1145

 

A Phase II Single-Arm, Feasibility Study of Dose-Dense Doxorubicin and Cyclophosphamide (AC) Followed by Eribulin Mesylate for the Adjuvant Treatment of Early-Stage Breast Cancer (EBC)

Poster SessionEribulin Mesylate

Abstract No: 2552

 

A Phase 1b Dose-Escalation Study of Eribulin Mesylate in Combination with Capecitabine in Patients with Advanced/ Metastatic Cancer

Poster Session Decitabine for Injection

Abstract No: 6559

 

Post Hoc Analysis of Relationship Between Baseline White Blood Cell Count and Survival Outcome in a Randomized Phase III Trial of Decitabine in Older Patients with Newly Diagnosed Acute Myeloid Leukemia
Poster SessionDecitabine for Injection

Abstract No: 6632

 

Post hoc analysis of relationship between baseline white blood cell count and renal and hepatic function and response in a randomized phase III trial of Decitabine in patients age 65 or
'/>"/>

SOURCE Eisai Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Arena and Eisai Announce Results of Re-Adjudication of Rat Mammary Tumors from Lorcaserin Carcinogenicity Study
2. Arena and Eisai Announce Completion of Study Measuring Lorcaserin Concentrations in Human Cerebrospinal Fluid and Related Analyses
3. Arena and Eisai Complete End-of-Review Meeting with FDA for Lorcaserin New Drug Application
4. Arena and Eisai Announce Upcoming Lorcaserin Presentations at Obesity 2010
5. Arena and Eisai Provide Update on Lorcaserin FDA Advisory Committee Meeting
6. Eisai Enters Licensing Agreement with Johns Hopkins Brain Science Institute
7. Eisai Inc. and the Alzheimers Association Honor Community Pharmacist for Outstanding Service to Individuals with Alzheimers Disease
8. Eisai Provides Preliminary Efficacy Update On EORTC Phase III Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes
9. Eisais Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting
10. Pharmacyclics Announces Oral Presentations and Clinical Update of Ibrutinib (PCI-32765) at the 2012 Annual Meeting of the American Society of Clinical Oncology
11. Telik Announces the Publication of Two Reports in the Journal Of Hematology & Oncology Describing the Results of a Clinical Study of Telintra® in Combination With Revlimid® and a Genomic Study Designed to Identify Genes That Predict Response to Teli
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... YORK , Nov. 24, 2014  Relmada Therapeutics, ... for the treatment of chronic pain, announced today that ... to present at the LD MICRO "MAIN Event" Micro-Cap ... will be held at the Luxe Sunset Bel Air ... Los Angeles, California . ...
(Date:11/24/2014)... Theater, LLC, announced today that their technology will be ... Europe,s first simulation center, The ... Planner (SRP) and the Surgical Navigation Advanced Platform (SNAP) ... navigation and augmented reality capabilities in the operating room ... Department of Neurosurgery at Mount Sinai Health System in ...
(Date:11/24/2014)... novembre 2014  Surgical Theater LLC ha ... esposta durante l,apertura in data 24 novembre ... la Fondazione IRCCS Istituto Neurologico Nazionale "C. ... (strumento di pianificazione chirurgica) e Surgical Navigation ... avanzata) saranno presentati in occasione dell,evento dedicato ...
Breaking Medicine Technology:Relmada Therapeutics To Present At LD MICRO Conference 2Surgical Theater's Technology to be Showcased at the Opening of the Besta NeuroSim Center in Milan, Italy 2Surgical Theater's Technology to be Showcased at the Opening of the Besta NeuroSim Center in Milan, Italy 3La tecnologia di Surgical Theater in mostra in Italia all'apertura del centro Besta NeuroSim di Milano 2La tecnologia di Surgical Theater in mostra in Italia all'apertura del centro Besta NeuroSim di Milano 3La tecnologia di Surgical Theater in mostra in Italia all'apertura del centro Besta NeuroSim di Milano 4
... and TORONTO, Feb. 27, 2012 Generex Biotechnology Corporation ... President of Generex subsidiary Antigen Express, Inc., will give ... be held in Boston, MA February 27-29.  The presentation, ... the Role of Th cells," will be given Wednesday, ...
... WHAT: Gearing up for its 2012 multi-city tour, the first stop ... with the Coconut Grove Chamber of Commerce, along with input ... has listed the "Top 25 Sights to See" in Miami ... – tourists and Miami locals alike – to vote on ...
Cached Medicine Technology:Generex Subsidiary Antigen Express to Present at Prestigious Cancer Immunotherapy Summit 2Generex Subsidiary Antigen Express to Present at Prestigious Cancer Immunotherapy Summit 3Generex Subsidiary Antigen Express to Present at Prestigious Cancer Immunotherapy Summit 4Transitions Optical Kicks-Off 2012 Multi-City "Sightseeing City Tour" with Voting Contest for "Top 10 Sights to See" in Miami 2
(Date:11/24/2014)... (PRWEB) November 24, 2014 Olaparib functions ... polymerase (PARP) and is one of the first PARP ... to creating some types of melanoma, and are often ... also sometimes gives their malignancies a exclusive weaknesses, as ... to fix their DNA and allow them to proceed ...
(Date:11/24/2014)... The Holiday Inn Westbury - Long ... Children's Association to donate various items consisting of ... other such items.The Association's program is aimed toward helping ... in nursing homes, assisted living facilities and nursing homes. ... being of seniors throughout the Long Island area. The ...
(Date:11/24/2014)... Raymond, Alberta (PRWEB) November 24, 2014 ... of people each day. They break up families, ... there is new hope for those that suffer,” ... “Ground-breaking scientific research is showing that our specialized ... , Hardy will appear on “Mind Over Matter”, ...
(Date:11/24/2014)... SafeHandles™ announced that they will be featured in ... airing via Discovery Channel. Dates and show times TBA. ... replaceable, and affordable germ protective device. This segment will ... adhesives to promote hand hygiene in high traffic and ... is the desire to make a positive impact in ...
(Date:11/24/2014)... Gersowitz Libo & Korek, P.C., a leading ... Tier recognition in the 2015 Edition of U.S. News-Best Lawyers ... a unique combination of quality law practice and breadth of ... honor and especially grateful to our clients whose continued support ... possible,” said Jeff S. Korek, senior partner at Gersowitz ...
Breaking Medicine News(10 mins):Health News:Olaparib Industry (CAS 763113-22-0) 2009-2019 Global and China Research Reports is Now Available at RnRMarketResearch.com 2Health News:Olaparib Industry (CAS 763113-22-0) 2009-2019 Global and China Research Reports is Now Available at RnRMarketResearch.com 3Health News:Olaparib Industry (CAS 763113-22-0) 2009-2019 Global and China Research Reports is Now Available at RnRMarketResearch.com 4Health News:The Holiday Inn Westbury - Long Island gives back to the local Long Island community, and also goes beyond borders to assist those in need during the 2014 Holiday Season 2Health News:The Holiday Inn Westbury - Long Island gives back to the local Long Island community, and also goes beyond borders to assist those in need during the 2014 Holiday Season 3Health News:Nutritional Mental Health Treatment Featured on Access Health Airing on Lifetime Television® 2Health News:Nutritional Mental Health Treatment Featured on Access Health Airing on Lifetime Television® 3Health News:New Episode of Innovations TV Series to Feature SafeHandles™ 2Health News:U.S. News-Best Lawyers “Best Law Firms” Names Gersowitz Libo & Korek P.C. a 2015 Tier 1 Ranking Firm 2
... Sept. 21 Roper Industries,Inc. (NYSE: ROP ) ... 2007, ended September 30, 2007, will be released after ... call to discuss these results,has been scheduled for 10:00 ... be accessed via webcast or by dialing +1 888-801-6506 ...
... SAN DIEGO, Sept. 21 ChemDiv, Inc. (San ... (CDRI, Moscow) is,undertaking a partnership with the Blokhin ... Medical Sciences, the US Department of Energy,(DOE), and ... novel small,molecule therapies for the prevention and treatment ...
... On Sept. 18, the,Michigan Association of Health Plans ... award reception at which eight Michigan HMOs received,the ... as these,are leading the way in serving participants ... "Michigan needs more,health care plans that expand outreach, ...
... are at high risk for preterm birth, giving them a ... babys chances of having serious lung problems after birth. , ... new study shows that repeat courses of corticosteroids are linked ... these mothers. , Our study shows that you get almost ...
... of studies shows big survival gains , THURSDAY, ... regimens of irinotecan, oxaliplatin, and molecular-targeted treatments are ... months longer than they did a few years ... say. , Researchers at the University of Ioannina ...
... 18, 2007 -- Recently, researchers at Iowa State University ... popular crop model. By zeroing in on early stages ... help improve yield predictions across a variety of environmental ... the September-October issue of Crop Science. , The Crop ...
Cached Medicine News:Health News:Chemical Diversity Initiates International Prostrate Cancer Discovery Partnership 2Health News:Chemical Diversity Initiates International Prostrate Cancer Discovery Partnership 3Health News:Eight Michigan HMOs, Two Providers, Take Top Honors for Quality Health Care 2Health News:Eight Michigan HMOs, Two Providers, Take Top Honors for Quality Health Care 3Health News:Multiple corticosteroid injections in pregnant women may increase cerebral palsy 2Health News:Experts Compare Colon Cancer Treatment Outcomes 2Health News:Simulating kernel production influences maize model accuracy 2
Khosla Precision and Quality in Medical and Surgical Products....
Khosla Precision and Quality in Medical and Surgical Products....
Khosla Precision and Quality in Medical and Surgical Products....
... For Anterior and Posterior segment surgeries ... using Ventury or Peristaltic Linear Aspiration. ... for specific cutting action. Easy to ... movement. Cutting speed-variable from 1- 600 ...
Medicine Products: